Table 2.
OR (95% CI) | ||
Variables | Unadjusted | Adjusted |
Beneficiary panel size | ||
<300 Beneficiaries | Reference | Reference |
300–600 Beneficiaries | 0.75 (0.59–0.95) | 0.74 (0.57–0.96)∗ |
>600 Beneficiaries | 0.60 (0.44–0.80) | 0.87 (0.41–0.79)∗ |
≥80% Female | 0.83 (0.63–1.11) | 0.87 (0.65–1.16) |
≥15% Black | 0.91 (0.71–1.17) | 0.74 (0.56–0.97)∗ |
≥50% 75 y of age or older | 1.49 (1.14–1.94) | 1.50 1.14–1.99)∗ |
<25% Dual eligible | 0.70 (0.56–0.88) | 0.70 (0.54–0.00∗ |
Comorbid conditions | ||
≥20% Cancer | 1.29 (0.96–1.73) | 0.94 (0.67–1.31) |
≥20% Congestive heart failure | 1.51 (1.22–1.87) | 1.48 (1.15–1.91)∗ |
≥20% Chronic kidney disease | 1.00 (0.81–1.24) | 0.74 (0.57–0.95)∗ |